The Pathogenesis of Rift Valley Fever
Abstract
:1. Introduction
2. Pathogenesis of RVF in Humans and Animals
2.1. Human
2.1.1. Self-Limiting Febrile Illness
2.1.2. Neurological Disorders
2.1.3. Vision Loss
2.1.4. Hemorrhagic Fever
2.1.5. Thrombosis
2.1.6. Possible Vertical Infection
2.2. Mouse
2.3. Rat
2.4. Hamster
2.5. Gerbil
2.6. Nonhuman Primates
2.7. Sheep
3. Viral Determinants of Virulence
3.1. Virus Life Cycle
3.2. Role of NSm Protein in Viral Virulence
3.3. Role of NSs Protein in Viral Virulence
3.4. Other Virulence Factors
4. Host Determinants of Virulence
4.1. Host Defense via Infection Route
4.2. Host Susceptibility
5. Conclusions
Acknowledgements
References and Notes
- Bishop, D.H.; Calisher, C.H.; Casals, J.; Chumakov, M.P.; Gaidamovich, S.Y.; Hannoun, C.; Lvov, D.K.; Marshall, I.D.; Oker-Blom, N.; Pettersson, R.F.; Porterfield, J.S.; Russell, P.K.; Shope, R.E.; Westaway, E.G. Bunyaviridae. Intervirology 1980, 14, 125–143. [Google Scholar] [CrossRef]
- Schmaljohn, C.; Nichol, S.T. Bunyaviridae. In Fields Virology, 5th ed.; Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, M.A., Roizman, B., Straus, S.E., Eds.; Lippincott, Williams & Wilkins: Philadelphia, PA, USA, 2007; pp. 1741–1789. [Google Scholar]
- Bird, B.H.; Ksiazek, T.G.; Nichol, S.T.; Maclachlan, N.J. Rift valley fever virus. J. Am. Vet. Med. Assoc. 2009, 234, 883–893. [Google Scholar] [CrossRef] [PubMed]
- Daubney, R.; Hudson, J.R. Enzootic hepatitis or rift valley fever: An undescribed virus disease of sheep cattle and man from east Africa. J. Path. Bact. 1931, 34, 545–579. [Google Scholar] [CrossRef]
- Easterday, B.C. Rift valley fever. Adv. Vet. Sci. 1965, 10, 65–127. [Google Scholar] [PubMed]
- Findlay, G.M.; Daubney, R. The virus of rift valley fever or enzootic hepatitis. Lancet 1931, 221, 1350–1351. [Google Scholar] [CrossRef]
- Peters, C.J.; Meegan, J.M. Rift valley fever. In Handbook Series of Zoonoses, Section B: Viral Zoonoses; CRC Press: Boca Raton, FL, USA, 1981; Volume 1, pp. 403–420. [Google Scholar]
- Weiss, K.E. Rift valley fever-a review. Bull. Epz. Dis. Afr. 1957, 5, 431–458. [Google Scholar]
- Linthicum, K.J.; Davies, F.G.; Kairo, A.; Bailey, C.L. Rift valley fever virus (family bunyaviridae, genus phlebovirus). Isolations from diptera collected during an inter-epizootic period in kenya. J. Hyg. (Lond.) 1985, 95, 197–209. [Google Scholar] [CrossRef]
- Pepin, M.; Bouloy, M.; Bird, B.H.; Kemp, A.; Paweska, J. Rift valley fever virus (bunyaviridae: Phlebovirus): An update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet. Res. 2010, 41, 61. [Google Scholar] [CrossRef]
- Thonnon, J.; Picquet, M.; Thiongane, Y.; Lo, M.; Sylla, R.; Vercruysse, J. Rift valley fever surveillance in the lower senegal river basin: Update 10 years after the epidemic. Trop. Med. Int. Health 1999, 4, 580–585. [Google Scholar] [CrossRef]
- Anyangu, A.S.; Gould, L.H.; Sharif, S.K.; Nguku, P.M.; Omolo, J.O.; Mutonga, D.; Rao, C.Y.; Lederman, E.R.; Schnabel, D.; Paweska, J.T.; Katz, M.; Hightower, A.; Njenga, M.K.; Feikin, D.R.; Breiman, R.F. Risk factors for severe rift valley fever infection in kenya, 2007. Am. J. Trop. Med. Hyg. 2010, 83, 14–21. [Google Scholar] [CrossRef]
- Andriamandimby, S.F.; Randrianarivo-Solofoniaina, A.E.; Jeanmaire, E.M.; Ravololomanana, L.; Razafimanantsoa, L.T.; Rakotojoelinandrasana, T.; Razainirina, J.; Hoffmann, J.; Ravalohery, J.P.; Rafisandratantsoa, J.T.; Rollin, P.E.; Reynes, J.M. Rift valley fever during rainy seasons, madagascar, 2008 and 2009. Emerg. Infect. Dis. 2010, 16, 963–970. [Google Scholar] [CrossRef] [PubMed]
- Linthicum, K.J.; Anyamba, A.; Tucker, C.J.; Kelley, P.W.; Myers, M.F.; Peters, C.J. Climate and satellite indicators to forecast rift valley fever epidemics in kenya. Science 1999, 285, 397–400. [Google Scholar] [CrossRef] [PubMed]
- Anyamba, A.; Chretien, J.P.; Small, J.; Tucker, C.J.; Formenty, P.B.; Richardson, J.H.; Britch, S.C.; Schnabel, D.C.; Erickson, R.L.; Linthicum, K.J. Prediction of a rift valley fever outbreak. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 955–959. [Google Scholar] [CrossRef] [PubMed]
- Abu-Elyazeed, R.; el-Sharkawy, S.; Olson, J.; Botros, B.; Soliman, A.; Salib, A.; Cummings, C.; Arthur, R. Prevalence of anti-rift-valley-fever igm antibody in abattoir workers in the nile delta during the 1993 outbreak in egypt. Bull. World Health Organ. 1996, 74, 155–158. [Google Scholar] [PubMed]
- Swai, E.S.; Schoonman, L. Prevalence of rift valley fever immunoglobulin g antibody in various occupational groups before the 2007 outbreak in tanzania. Vector Borne Zoonotic Dis. 2009, 9, 579–582. [Google Scholar] [CrossRef]
- Turell, M.J.; Gargan, T.P., 2nd; Bailey, C.L. Replication and dissemination of rift valley fever virus in culex pipiens. Am. J. Trop. Med. Hyg. 1984, 33, 176–181. [Google Scholar] [CrossRef]
- Gargan, T.P., 2nd; Clark, G.G.; Dohm, D.J.; Turell, M.J.; Bailey, C.L. Vector potential of selected north american mosquito species for rift valley fever virus. Am. J. Trop. Med. Hyg. 1988, 38, 440–446. [Google Scholar] [CrossRef]
- Turell, M.J.; Bailey, C.L.; Beaman, J.R. Vector competence of a houston, texas strain of aedes albopictus for rift valley fever virus. J. Am. Mosq. Control Assoc. 1988, 4, 94–96. [Google Scholar]
- Schwentker, F.F.; Rivers, T.M. Report of a fatal laboratory infection complicated by thrombophlebitis. J. Exp. Med. 1933, 59, 305–313. [Google Scholar] [CrossRef]
- Kitchen, S.F. Laboratory infections with the virus of rift valley fever. Am. J. Trop. Med. 1934, 14, 547–564. [Google Scholar]
- Francis, T.; Magill, T.P. Rift valley fever: A report of three cases of laboratory infection and the experimental transmission of the disease to ferrets. J. Exp. Med. 1935, 62, 433–448. [Google Scholar] [CrossRef] [PubMed]
- Sabin, A.B.; Blumberg, R.W. Human infection with rift valley fever virus and immunity twelve years after single attack. Proc. Soc. Exp. Biol. Med. 1947, 64, 385–389. [Google Scholar] [CrossRef] [PubMed]
- Smithburn, K.C.; Mahaffy, A.F.; et al. Rift valley fever; accidental infections among laboratory workers. J. Immunol. 1949, 62, 213–227. [Google Scholar] [CrossRef] [PubMed]
- Mundel, B.; Gear, J. Rift valley fever; i. The occurrence of human cases in johannesburg. S. Afr. Med. J. 1951, 25, 797–800. [Google Scholar]
- Gear, J.; De Meillon, B.; Measroch, V.; Davis, D.H.; Harwin, H. Rift valley fever in south africa. 2. The occurrence of human cases in the orange free state, the north-western cape province, the western and southern transvaal. B. Field and laboratory investigation. S. Afr. Med. J. 1951, 25, 908–912. [Google Scholar]
- Joubert, J.D.; Ferguson, A.L.; Gear, J. Rift valley fever in south africa: 2. The occurrence of human cases in the orange free state, the north-western cape province, the western and southern transvaal. A epidemiological and clinical findings. S. Afr. Med. J. 1951, 25, 890–891. [Google Scholar]
- Maar, S.A.; Swanepoel, R.; Gelfand, M. Rift valley fever encephalitis. A description of a case. Cent. Afr. J. Med. 1979, 25, 8–11. [Google Scholar]
- Alrajhi, A.A.; Al-Semari, A.; Al-Watban, J. Rift valley fever encephalitis. Emerg. Infect. Dis. 2004, 10, 554–555. [Google Scholar] [CrossRef]
- Laughlin, L.W.; Girgis, N.I.; Meegan, J.M.; Strausbaugh, L.J.; Yassin, M.W.; Watten, R.H. Clinical studies on rift valley fever. Part 2: Ophthalmologic and central nervous system complications. J. Egypt. Publ. Health Assoc. 1978, 53, 183–184. [Google Scholar]
- van Velden, D.J.; Meyer, J.D.; Olivier, J.; Gear, J.H.; McIntosh, B. Rift valley fever affecting humans in south africa: A clinicopathological study. S. Afr. Med. J. 1977, 51, 867–871. [Google Scholar]
- Siam, A.L.; Meegan, J.M.; Gharbawi, K.F. Rift valley fever ocular manifestations: Observations during the 1977 epidemic in egypt. Br. J. Ophthalmol. 1980, 64, 366–374. [Google Scholar] [CrossRef]
- Salib, M.; Sobhy, M.I. Epidemic maculopathy. Bull. Ophthalmol. Soc. Egypt 1978, 71, 103–106. [Google Scholar] [PubMed]
- Deutman, A.F.; Klomp, H.J. Rift valley fever retinitis. Am. J. Ophthalmol. 1981, 92, 38–42. [Google Scholar] [CrossRef] [PubMed]
- Schrire, L. Macular changes in rift valley fever. S. Afr. Med. J. 1951, 25, 926–930. [Google Scholar]
- Freed, I. Rift valley fever in man, complicated by retinal changes and loss of vision. S. Afr. Med. J. 1951, 25, 930–932. [Google Scholar] [PubMed]
- Siam, A.L.; Meegan, J.M. Ocular disease resulting from infection with rift valley fever virus. Trans. R. Soc. Trop. Med. Hyg. 1980, 74, 539–541. [Google Scholar] [CrossRef]
- Al-Hazmi, A.; Al-Rajhi, A.A.; Abboud, E.B.; Ayoola, E.A.; Al-Hazmi, M.; Saadi, R.; Ahmed, N. Ocular complications of rift valley fever outbreak in saudi arabia. Ophthalmology 2005, 112, 313–318. [Google Scholar] [CrossRef]
- Siam, A.L.; Gharbawi, K.F.; Meegan, J.M. Ocular complications of rift valley fever. J. Egypt. Publ. Health Assoc. 1978, 53, 185–186. [Google Scholar]
- Ayoub, M.; Barhoma, G.; Zaghlol, I. Ocular manifestations of rift valley fever. Bull. Ophthalmol. Soc. Egypt 1978, 71, 125–133. [Google Scholar]
- Swanepoel, R.; Manning, B.; Watt, J.A. Fatal rift valley fever of man in rhodesia. Cent. Afr. J. Med. 1979, 25, 1–8. [Google Scholar]
- Yassin, W. Clinico-pathological picture in five human cases died with rift valley fever. J. Egypt. Publ. Health Assoc. 1978, 53, 191–193. [Google Scholar]
- Abdel-Wahab, K.S.; El Baz, L.M.; El-Tayeb, E.M.; Omar, H.; Ossman, M.A.; Yasin, W. Rift valley fever virus infections in egypt: Pathological and virological findings in man. Trans. R. Soc. Trop. Med. Hyg. 1978, 72, 392–396. [Google Scholar] [CrossRef] [PubMed]
- Al-Hazmi, M.; Ayoola, E.A.; Abdurahman, M.; Banzal, S.; Ashraf, J.; El-Bushra, A.; Hazmi, A.; Abdullah, M.; Abbo, H.; Elamin, A.; Al-Sammani el, T.; Gadour, M.; Menon, C.; Hamza, M.; Rahim, I.; Hafez, M.; Jambavalikar, M.; Arishi, H.; Aqeel, A. Epidemic rift valley fever in saudi arabia: A clinical study of severe illness in humans. Clin. Infect. Dis. 2003, 36, 245–252. [Google Scholar] [CrossRef]
- Al-Khuwaitir, T.S.; Al-Moghairi, A.M.; Sherbeeni, S.M.; Al-Ghamdi, A.S. Rift valley fever hepatitis complicated by disseminated intravascular coagulation and hepatorenal syndrome. Saudi Med. J. 2004, 25, 528–531. [Google Scholar] [PubMed]
- El Imam, M.; El Sabiq, M.; Omran, M.; Abdalkareem, A.; El Gaili Mohamed, M.A.; Elbashir, A.; Khalafala, O. Acute renal failure associated with the rift valley fever: A single center study. Saudi J. Kidney Dis. Transpl. 2009, 20, 1047–1052. [Google Scholar] [PubMed]
- Abdel-Aziz, A.A.; Meegan, J.M.; Laughlin, L.W. Rift valley fever as a possible cause of human abortions. Trans. R. Soc. Trop. Med. Hyg. 1980, 74, 685–686. [Google Scholar] [CrossRef]
- Arishi, H.M.; Aqeel, A.Y.; Al Hazmi, M.M. Vertical transmission of fatal rift valley fever in a newborn. Ann. Trop. Paediatr. 2006, 26, 251–253. [Google Scholar] [CrossRef]
- Vialat, P.; Billecocq, A.; Kohl, A.; Bouloy, M. The s segment of rift valley fever phlebovirus (bunyaviridae) carries determinants for attenuation and virulence in mice. J. Virol. 2000, 74, 1538–1543. [Google Scholar] [CrossRef]
- Bouloy, M.; Janzen, C.; Vialat, P.; Khun, H.; Pavlovic, J.; Huerre, M.; Haller, O. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein nss. J. Virol. 2001, 75, 1371–1377. [Google Scholar] [CrossRef]
- Smith, D.R.; Steele, K.E.; Shamblin, J.; Honko, A.; Johnson, J.; Reed, C.; Kennedy, M.; Chapman, J.L.; Hensley, L.E. The pathogenesis of rift valley fever virus in the mouse model. Virology 2010, 407, 256–267. [Google Scholar] [CrossRef]
- Mims, C.A. Rift valley fever virus in mice. Iii. Further quantitative features of the infective process. Br. J. Exp. Pathol. 1956, 37, 120–128. [Google Scholar]
- Mims, C.A. Rift valley fever virus in mice. I. General features of the infection. Br. J. Exp. Pathol. 1956, 37, 99–109. [Google Scholar] [PubMed]
- McGavran, M.H.; Easterday, B.C. Rift valley fever virus hepatitis: Light and electron microscopic studies in the mouse. Am. J. Pathol. 1963, 42, 587–607. [Google Scholar] [PubMed]
- Tomori, O.; Kasali, O. Pathogenicity of different strains of rift valley fever virus in swiss albino mice. Br. J. Exp. Pathol. 1979, 60, 417–422. [Google Scholar] [PubMed]
- Chieco, P.; Derenzini, M. The feulgen reaction 75 years on. Histochem. Cell Biol. 1999, 111, 345–358. [Google Scholar] [CrossRef]
- Swanepoel, R.; Blackburn, N.K. Demonstration of nuclear immunofluorescence in rift valley fever infected cells. J. Gen. Virol. 1977, 34, 557–561. [Google Scholar] [CrossRef]
- Struthers, J.K.; Swanepoel, R. Identification of a major non-structural protein in the nuclei of rift valley fever virus-infected cells. J. Gen. Virol. 1982, 60, 381–384. [Google Scholar] [CrossRef]
- Yadani, F.Z.; Kohl, A.; Prehaud, C.; Billecocq, A.; Bouloy, M. The carboxy-terminal acidic domain of rift valley fever virus nss protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein. J. Virol. 1999, 73, 5018–5025. [Google Scholar] [CrossRef]
- Morrill, J.C.; Ikegami, T.; Yoshikawa-Iwata, N.; Lokugamage, N.; Won, S.; Terasaki, K.; Zamoto-Niikura, A.; Peters, C.J.; Makino, S. Rapid accumulation of virulent rift valley fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m rna. PLoS ONE 5, e9986. [CrossRef]
- Findlay, G.M.; Howard, E.M. The susceptibility of rats to rift valley fever in relation to age. Ann. Trop. Med. Parasitol. 1952, 46, 33–37. [Google Scholar] [CrossRef]
- Peters, C.J.; Anderson, G.W.J. Pathogenesis of rift valley fever. Contr. Epidem. Biostatist. 1981, 3, 21–41. [Google Scholar]
- Peters, C.J.; Slone, T.W. Inbred rat strains mimic the disparate human response to rift valley fever virus infection. J. Med. Virol. 1982, 10, 45–54. [Google Scholar] [CrossRef]
- Anderson, G.W., Jr.; Slone, T.W., Jr.; Peters, C.J. Pathogenesis of rift valley fever virus (rvfv) in inbred rats. Microb. Pathog. 1987, 2, 283–293. [Google Scholar] [CrossRef]
- Ritter, M.; Bouloy, M.; Vialat, P.; Janzen, C.; Haller, O.; Frese, M. Resistance to rift valley fever virus in rattus norvegicus: Genetic variability within certain ‘inbred’ strains. J. Gen. Virol. 2000, 81, 2683–2688. [Google Scholar] [CrossRef]
- Niklasson, B.S.; Meadors, G.F.; Peters, C.J. Active and passive immunization against rift valley fever virus infection in syrian hamsters. Acta Pathol. Microbiol. Immunol. Scand. [C] 1984, 92, 197–200. [Google Scholar] [CrossRef] [PubMed]
- Anderson, G.W., Jr.; Slone, T.W., Jr.; Peters, C.J. The gerbil, meriones unguiculatus, a model for rift valley fever viral encephalitis. Arch. Virol. 1988, 102, 187–196. [Google Scholar] [CrossRef]
- Peters, C.J.; Jones, D.; Trotter, R.; Donaldson, J.; White, J.; Stephen, E.; Slone, T.W., Jr. Experimental rift valley fever in rhesus macaques. Arch. Virol. 1988, 99, 31–44. [Google Scholar] [CrossRef]
- Morrill, J.C.; Jennings, G.B.; Johnson, A.J.; Cosgriff, T.M.; Gibbs, P.H.; Peters, C.J. Pathogenesis of rift valley fever in rhesus monkeys: Role of interferon response. Arch. Virol. 1990, 110, 195–212. [Google Scholar] [CrossRef]
- Morrill, J.C.; Jennings, G.B.; Cosgriff, T.M.; Gibbs, P.H.; Peters, C.J. Prevention of rift valley fever in rhesus monkeys with interferon-alpha. Rev. Infect. Dis. 1989, 11, S815–825. [Google Scholar] [CrossRef]
- Findlay, G.M. The infectivity of rift valley fever for monkeys. Trans. Roy. Soc. Trop. Med. Hyg. 1932, 26, 161–168. [Google Scholar] [CrossRef]
- Davies, F.G.; Clausen, B.; Lund, L.J. The pathogenicity of rift valley fever virus for the baboon. Trans. R. Soc. Trop. Med. Hyg. 1972, 66, 363–365. [Google Scholar] [CrossRef]
- Easterday, B.C.; Murphy, L.C.; Bennett, D.G. Experimental rift valley fever in lambs and sheeps. Am. J. Vet. Res. 1962, 23, 1231–1240. [Google Scholar]
- Tomori, O. Clinical, virological and serological response of the west african dwarf sheep to experimental infection with different strains of rift valley fever virus. Res. Vet. Sci. 1979, 26, 152–159. [Google Scholar] [CrossRef] [PubMed]
- Busquets, N.; Xavier, F.; Martin-Folgar, R.; Lorenzo, G.; Galindo-Cardiel, I.; del Val, B.P.; Rivas, R.; Iglesias, J.; Rodriguez, F.; Solanes, D.; Domingo, M.; Brun, A. Experimental infection of young adult european breed sheep with rift valley fever virus field isolates. Vector Borne Zoonotic Dis. 2010, 10, 689–696. [Google Scholar] [CrossRef]
- Olaleye, O.D.; Tomori, O.; Fajimi, J.L.; Schmitz, H. Experimental infection of three nigerian breeds of sheep with the zinga strain of the rift valley fever virus. Rev. Elev. Med. Vet. Pays. Trop. 1996, 49, 6–16. [Google Scholar] [CrossRef]
- Yedloutschnig, R.J.; Dardiri, A.H.; Mebus, C.A.; Walker, J.S. Abortion in vaccinated sheep and cattle after challenge with rift valley fever virus. Vet. Rec. 1981, 109, 383–384. [Google Scholar] [CrossRef] [PubMed]
- Coetzer, J.A.; Barnard, B.J. Hydrops amnii in sheep associated with hydranencephaly and arthrogryposis with wesselsbron disease and rift valley fever viruses as aetiological agents. Onderstepoort J. Vet. Res. 1977, 44, 119–126. [Google Scholar] [PubMed]
- Hunter, P.; Erasmus, B.J.; Vorster, J.H. Teratogenicity of a mutagenised rift valley fever virus (mvp 12) in sheep. Onderstepoort J. Vet. Res. 2002, 69, 95–98. [Google Scholar]
- Morrill, J.C.; Carpenter, L.; Taylor, D.; Ramsburg, H.H.; Quance, J.; Peters, C.J. Further evaluation of a mutagen-attenuated rift valley fever vaccine in sheep. Vaccine 1991, 9, 35–41. [Google Scholar] [CrossRef]
- Morrill, J.C.; Jennings, G.B.; Caplen, H.; Turell, M.J.; Johnson, A.J.; Peters, C.J. Pathogenicity and immunogenicity of a mutagen-attenuated rift valley fever virus immunogen in pregnant ewes. Am. J. Vet. Res. 1987, 48, 1042–1047. [Google Scholar]
- Muller, R.; Saluzzo, J.F.; Lopez, N.; Dreier, T.; Turell, M.; Smith, J.; Bouloy, M. Characterization of clone 13, a naturally attenuated avirulent isolate of rift valley fever virus, which is altered in the small segment. Am. J. Trop. Med. Hyg. 1995, 53, 405–411. [Google Scholar] [CrossRef] [PubMed]
- Dungu, B.; Louw, I.; Lubisi, A.; Hunter, P.; von Teichman, B.F.; Bouloy, M. Evaluation of the efficacy and safety of the rift valley fever clone 13 vaccine in sheep. Vaccine 2010, 28, 4581–4587. [Google Scholar] [CrossRef]
- Easterday, B.C.; Mc, G.M.; Rooney, J.R.; Murphy, L.C. The pathogenesis of rift valley fever in lambs. Am. J. Vet. Res. 1962, 23, 470–479. [Google Scholar] [PubMed]
- Van der Lugt, J.J.; Coetzer, J.A.; Smit, M.M. Distribution of viral antigen in tissues of new-born lambs infected with rift valley fever virus. Onderstepoort J. Vet. Res. 1996, 63, 341–347. [Google Scholar]
- Coetzer, J.A. The pathology of rift valley fever. I. Lesions occurring in natural cases in new-born lambs. Onderstepoort J. Vet. Res. 1977, 44, 205–211. [Google Scholar] [PubMed]
- Walker, J.S.; Remmele, N.S.; Carter, R.C.; Mitten, J.Q.; Schuh, L.G.; Stephen, E.L.; Klein, F. The clinical aspects of rift valley fever virus in household pets. I. Susceptibility of the dog. J. Infect. Dis. 1970, 121, 9–18. [Google Scholar] [CrossRef]
- Walker, J.S.; Stephen, E.L.; Remmele, N.S.; Carter, R.C.; Mitten, J.Q.; Schuh, L.G.; Klein, F. The clinical aspects of rift valley fever virus in household pets. Ii. Susceptibility of the cat. J. Infect. Dis. 1970, 121, 19–24. [Google Scholar] [CrossRef]
- Keefer, G.V.; Zebarth, G.L.; Allen, W.P. Susceptibility of dogs and cats to rift valley fever by inhalation or ingestion of virus. J. Infect. Dis. 1972, 125, 307–309. [Google Scholar] [CrossRef]
- Scott, G.R. Pigs and rift valley fever. Nature 1963, 200, 919–920. [Google Scholar] [CrossRef]
- Scott, G.R.; Coackley, W.; Roach, R.W.; Cowdy, N.R. Rift valley fever in camels. J. Pathol. Bacteriol. 1963, 86, 229–231. [Google Scholar] [CrossRef]
- Shimshony, A.; Barzilai, R. Rift valley fever. Adv. Vet. Sci. Comp Med 1983, 27, 347–425. [Google Scholar]
- Filone, C.M.; Heise, M.; Doms, R.W.; Bertolotti-Ciarlet, A. Development and characterization of a rift valley fever virus cell-cell fusion assay using alphavirus replicon vectors. Virology 2006, 356, 155–164. [Google Scholar] [CrossRef]
- Lozach, P.Y.; Mancini, R.; Bitto, D.; Meier, R.; Oestereich, L.; Overby, A.K.; Pettersson, R.F.; Helenius, A. Entry of bunyaviruses into mammalian cells. Cell Host Microbe 2010, 7, 488–499. [Google Scholar] [CrossRef]
- Raymond, D.D.; Piper, M.E.; Gerrard, S.R.; Smith, J.L. Structure of the rift valley fever virus nucleocapsid protein reveals another architecture for rna encapsidation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 11769–11774. [Google Scholar] [CrossRef]
- Ikegami, T.; Won, S.; Peters, C.J.; Makino, S. Rift valley fever virus nss mrna is transcribed from an incoming anti-viral-sense s rna segment. J. Virol. 2005, 79, 12106–12111. [Google Scholar] [CrossRef] [PubMed]
- Shi, X.; Kohl, A.; Li, P.; Elliott, R.M. Role of the cytoplasmic tail domains of bunyamwera orthobunyavirus glycoproteins gn and gc in virus assembly and morphogenesis. J. Virol. 2007, 81, 10151–10160. [Google Scholar] [CrossRef] [PubMed]
- Overby, A.K.; Pettersson, R.F.; Neve, E.P. The glycoprotein cytoplasmic tail of uukuniemi virus (bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging. J. Virol. 2007, 81, 3198–3205. [Google Scholar] [CrossRef] [PubMed]
- Terasaki, K.; Murakami, S.; Lokugamage, K.G.; Makino, S. Mechanism of tripartite rna genome packaging in rift valley fever virus. Proc. Natl. Acad. Sci. U. S. A. 108, 804–809. [CrossRef]
- Freiberg, A.N.; Sherman, M.B.; Morais, M.C.; Holbrook, M.R.; Watowich, S.J. Three-dimensional organization of rift valley fever virus revealed by cryoelectron tomography. J. Virol. 2008, 82, 10341–10348. [Google Scholar] [CrossRef] [PubMed]
- Huiskonen, J.T.; Overby, A.K.; Weber, F.; Grunewald, K. Electron cryo-microscopy and single-particle averaging of rift valley fever virus: Evidence for gn-gc glycoprotein heterodimers. J. Virol. 2009, 83, 3762–3769. [Google Scholar] [CrossRef]
- Kakach, L.T.; Suzich, J.A.; Collett, M.S. Rift valley fever virus m segment: Phlebovirus expression strategy and protein glycosylation. Virology 1989, 170, 505–510. [Google Scholar] [CrossRef]
- Kakach, L.T.; Wasmoen, T.L.; Collett, M.S. Rift valley fever virus m segment: Use of recombinant vaccinia viruses to study phlebovirus gene expression. J. Virol. 1988, 62, 826–833. [Google Scholar] [CrossRef] [PubMed]
- Gerrard, S.R.; Nichol, S.T. Synthesis, proteolytic processing and complex formation of n-terminally nested precursor proteins of the rift valley fever virus glycoproteins. Virology 2007, 357, 124–133. [Google Scholar] [CrossRef]
- Struthers, J.K.; Swanepoel, R.; Shepherd, S.P. Protein synthesis in rift valley fever virus-infected cells. Virology 1984, 134, 118–124. [Google Scholar] [CrossRef] [PubMed]
- Won, S.; Ikegami, T.; Peters, C.J.; Makino, S. Nsm and 78-kilodalton proteins of rift valley fever virus are nonessential for viral replication in cell culture. J. Virol. 2006, 80, 8274–8278. [Google Scholar] [CrossRef] [PubMed]
- Gerrard, S.R.; Bird, B.H.; Albarino, C.G.; Nichol, S.T. The nsm proteins of rift valley fever virus are dispensable for maturation, replication and infection. Virology 2007, 359, 459–465. [Google Scholar] [CrossRef]
- Ikegami, T.; Won, S.; Peters, C.J.; Makino, S. Rescue of infectious rift valley fever virus entirely from cdna, analysis of virus lacking the nss gene, and expression of a foreign gene. J. Virol. 2006, 80, 2933–2940. [Google Scholar] [CrossRef]
- Bird, B.H.; Albarino, C.G.; Nichol, S.T. Rift valley fever virus lacking nsm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. Virology 2007, 362, 10–15. [Google Scholar] [CrossRef]
- Won, S.; Ikegami, T.; Peters, C.J.; Makino, S. Nsm protein of rift valley fever virus suppresses virus-induced apoptosis. J. Virol. 2007, 81, 13335–13345. [Google Scholar] [CrossRef]
- Billecocq, A.; Spiegel, M.; Vialat, P.; Kohl, A.; Weber, F.; Bouloy, M.; Haller, O. Nss protein of rift valley fever virus blocks interferon production by inhibiting host gene transcription. J. Virol. 2004, 78, 9798–9806. [Google Scholar] [CrossRef]
- Le May, N.; Dubaele, S.; Proietti De Santis, L.; Billecocq, A.; Bouloy, M.; Egly, J.M. Tfiih transcription factor, a target for the rift valley hemorrhagic fever virus. Cell 2004, 116, 541–550. [Google Scholar] [CrossRef] [PubMed]
- Le May, N.; Mansuroglu, Z.; Leger, P.; Josse, T.; Blot, G.; Billecocq, A.; Flick, R.; Jacob, Y.; Bonnefoy, E.; Bouloy, M. A sap30 complex inhibits ifn-beta expression in rift valley fever virus infected cells. PLoS Pathog. 2008, 4, e13. [Google Scholar] [CrossRef] [PubMed]
- Bushar, G.; Sagripanti, J.L. Replication and physical parameters important for preparing purified junin virus. J. Virol. Methods 1993, 41, 147–156. [Google Scholar] [CrossRef]
- Rawls, W.E.; Banerjee, S.N.; McMillan, C.A.; Buchmeier, M.J. Inhibition of pichinde virus replication by actinomycin d. J. Gen. Virol. 1976, 33, 421–434. [Google Scholar] [CrossRef] [PubMed]
- Buck, L.L.; Pfau, C.J. Inhibition of lymphocytic choriomeningitis virus replication by actinomycin d and 6-azauridine. Virology 1969, 37, 698–701. [Google Scholar] [CrossRef]
- Hall, W.W.; ter Meulen, V. The effects of actinomycin d on rna synthesis in measles virus-infected cells. J. Gen. Virol. 1977, 34, 391–396. [Google Scholar] [CrossRef]
- Baric, R.S.; Carlin, L.J.; Johnston, R.E. Requirement for host transcription in the replication of sindbis virus. J. Virol. 1983, 45, 200–205. [Google Scholar] [CrossRef]
- Nakhasi, H.L.; Zheng, D.X.; Hewlett, I.K.; Liu, T.Y. Rubella virus replication: Effect of interferons and actinomycin d. Virus Res. 1988, 10, 1–15. [Google Scholar] [CrossRef]
- Grado, C.; Ohlbaum, A. The effect of rifampicin, actinomycin d and mitomycin c on poliovirus and foot-and-mouth disease virus replication. J. Gen. Virol. 1973, 21, 297–303. [Google Scholar] [CrossRef]
- Grado, C.; Fischer, S.; Contreras, G. The inhibition by actinomycin d of poliovirus multiplication hep 2 cells. Virology 1965, 27, 623–625. [Google Scholar] [CrossRef]
- Kennedy, D.A.; Johnson-Lussenburg, C.M. Inhibition of coronavirus 229e replication by actinomycin d. J. Virol. 1979, 29, 401–404. [Google Scholar] [CrossRef] [PubMed]
- Lewis, E.L.; Harbour, D.A.; Beringer, J.E.; Grinsted, J. Differential in vitro inhibition of feline enteric coronavirus and feline infectious peritonitis virus by actinomycin d. J. Gen. Virol. 1992, 73, 3285–3288. [Google Scholar] [CrossRef]
- Yamazaki, S.; Notkins, A.L. Inhibition of replication of lactic dehydrogenase virus by actinomycin. J. Virol. 1973, 11, 473–478. [Google Scholar] [CrossRef]
- Ikegami, T.; Narayanan, K.; Won, S.; Kamitani, W.; Peters, C.J.; Makino, S. Rift valley fever virus nss protein promotes post-transcriptional downregulation of protein kinase pkr and inhibits eif2alpha phosphorylation. PLoS Pathog. 2009, 5, e1000287. [Google Scholar] [CrossRef] [PubMed]
- Habjan, M.; Pichlmair, A.; Elliott, R.M.; Overby, A.K.; Glatter, T.; Gstaiger, M.; Superti-Furga, G.; Unger, H.; Weber, F. Nss protein of rift valley fever virus induces the specific degradation of the double-stranded rna-dependent protein kinase. J. Virol. 2009, 83, 4365–4375. [Google Scholar] [CrossRef] [PubMed]
- Yang, Y.L.; Reis, L.F.; Pavlovic, J.; Aguzzi, A.; Schafer, R.; Kumar, A.; Williams, B.R.; Aguet, M.; Weissmann, C. Deficient signaling in mice devoid of double-stranded rna-dependent protein kinase. EMBO J. 1995, 14, 6095–6106. [Google Scholar] [CrossRef]
- Balachandran, S.; Roberts, P.C.; Brown, L.E.; Truong, H.; Pattnaik, A.K.; Archer, D.R.; Barber, G.N. Essential role for the dsrna-dependent protein kinase pkr in innate immunity to viral infection. Immunity 2000, 13, 129–141. [Google Scholar] [CrossRef]
- Frese, M.; Kochs, G.; Feldmann, H.; Hertkorn, C.; Haller, O. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human mxa protein. J. Virol. 1996, 70, 915–923. [Google Scholar] [CrossRef] [PubMed]
- Bird, B.H.; Khristova, M.L.; Rollin, P.E.; Ksiazek, T.G.; Nichol, S.T. Complete genome analysis of 33 ecologically and biologically diverse rift valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry. J. Virol. 2007, 81, 2805–2816. [Google Scholar] [CrossRef]
- Anderson, G.W., Jr.; Peters, C.J. Viral determinants of virulence for rift valley fever (rvf) in rats. Microb. Pathog. 1988, 5, 241–250. [Google Scholar] [CrossRef]
- Caplen, H.; Peters, C.J.; Bishop, D.H. Mutagen-directed attenuation of rift valley fever virus as a method for vaccine development. J. Gen. Virol. 1985, 66, 2271–2277. [Google Scholar] [CrossRef]
- Billecocq, A.; Gauliard, N.; Le May, N.; Elliott, R.M.; Flick, R.; Bouloy, M. Rna polymerase i-mediated expression of viral rna for the rescue of infectious virulent and avirulent rift valley fever viruses. Virology 2008, 378, 377–384. [Google Scholar] [CrossRef] [PubMed]
- Ikegami, T.; Morrill, J.C.; Peters, C.J.; Makino, S. Reassortant RVFV between MP-12 and ZH501 by reverese genetics; The University of Texas Medical Branch: Galveston, TX, USA, Unpublished work; 2011. [Google Scholar]
- Keegan, K.; Collett, M.S. Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the g2 glycoprotein of rift valley fever virus. J. Virol. 1986, 58, 263–270. [Google Scholar] [CrossRef] [PubMed]
- Ikegami, T.; Makino, S. Rift valley fever vaccines. Vaccine 2009, 27, D69–D72. [Google Scholar] [CrossRef] [PubMed]
- Randall, R.; Binn, L.N.; Harrison, V.R. Immunization against rift valley fever virus. Studies onthe immunogenicity of lyophilized formalin-inactivated vaccine. J. Immunol. 1964, 93, 293–299. [Google Scholar] [CrossRef] [PubMed]
- Randall, R.; Gibbs, C.J., Jr.; Aulisio, C.G.; Binn, L.N.; Harrison, V.R. The development of a formalin-killed rift valley fever virus vaccine for use in man. J. Immunol. 1962, 89, 660–671. [Google Scholar] [CrossRef]
- Smithburn, K.C. Rift valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine. Br. J. Exp. Pathol. 1949, 30, 1–16. [Google Scholar]
- Anderson, G.W., Jr.; Lee, J.O.; Anderson, A.O.; Powell, N.; Mangiafico, J.A.; Meadors, G. Efficacy of a rift valley fever virus vaccine against an aerosol infection in rats. Vaccine 1991, 9, 710–714. [Google Scholar] [CrossRef]
- Schmaljohn, C.S.; Parker, M.D.; Ennis, W.H.; Dalrymple, J.M.; Collett, M.S.; Suzich, J.A.; Schmaljohn, A.L. Baculovirus expression of the m genome segment of rift valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins. Virology 1989, 170, 184–192. [Google Scholar] [CrossRef]
- Harrington, D.G.; Lupton, H.W.; Crabbs, C.L.; Peters, C.J.; Reynolds, J.A.; Slone, T.W., Jr. Evaluation of a formalin-inactivated rift valley fever vaccine in sheep. Am. J. Vet. Res. 1980, 41, 1559–1564. [Google Scholar]
- Kasahara, S.; Koyama, H. Long term existence of rift valley fever virus in immune mice. Kitasato Arch. Exp. Med. 1973, 46, 105–112. [Google Scholar] [PubMed]
- Mandell, R.B.; Koukuntla, R.; Mogler, L.J.; Carzoli, A.K.; Freiberg, A.N.; Holbrook, M.R.; Martin, B.K.; Staplin, W.R.; Vahanian, N.N.; Link, C.J.; Flick, R. A replication-incompetent rift valley fever vaccine: Chimeric virus-like particles protect mice and rats against lethal challenge. Virology 397, 187–198. [CrossRef] [PubMed]
- Lamere, M.W.; Lam, H.T.; Moquin, A.; Haynes, L.; Lund, F.E.; Randall, T.D.; Kaminski, D.A. Contributions of antinucleoprotein igg to heterosubtypic immunity against influenza virus. J. Immunol. 186, 4331–4339. [CrossRef] [PubMed]
- Virelizier, J.L.; Allison, A.C.; Oxford, J.S.; Schild, G.C. Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells. Nature 1977, 266, 52–54. [Google Scholar] [CrossRef]
- Yewdell, J.W.; Frank, E.; Gerhard, W. Expression of influenza a virus internal antigens on the surface of infected p815 cells. J. Immunol. 1981, 126, 1814–1819. [Google Scholar] [CrossRef]
- Eddy, G.A.; Peters, C.J.; Meadors, G.; Cole Jr, F.E. Rift valley fever vaccine for humans. Contr. Epidem. Biostatist. 1981, 3, 124–141. [Google Scholar]
- Brown, J.L.; Dominik, J.W.; Morrissey, R.L. Respiratory infectivity of a recently isolated egyptian strain of rift valley fever virus. Infect. Immun. 1981, 33, 848–853. [Google Scholar] [CrossRef]
- Anderson, A.O.; Snyder, L.F.; Pitt, M.L.; Wood, O.L. Mucosal priming alters pathogenesis of rift valley fever. Adv. Exp. Med. Biol. 1988, 237, 717–723. [Google Scholar]
- Gerrard, S.R.; Rollin, P.E.; Nichol, S.T. Bidirectional infection and release of rift valley fever virus in polarized epithelial cells. Virology 2002, 301, 226–235. [Google Scholar] [CrossRef]
- Anderson, G.W., Jr.; Slayter, M.V.; Hall, W.; Peters, C.J. Pathogenesis of a phleboviral infection (punta toro virus) in golden syrian hamsters. Arch. Virol. 1990, 114, 203–212. [Google Scholar] [CrossRef]
- Fisher, A.F.; Tesh, R.B.; Tonry, J.; Guzman, H.; Liu, D.; Xiao, S.Y. Induction of severe disease in hamsters by two sandfly fever group viruses, Punta Toro and Gabek Forest (Phlebovirus, Bunyaviridae), similar to that caused by Rift Valley fever virus. Am. J. Trop. Med. Hyg. 2003, 69, 269–276. [Google Scholar] [CrossRef] [PubMed]
- Pifat, D.Y.; Smith, J.F. Punta Toro virus infection of C57BL/6J mice: A model for phlebovirus-induced disease. Microb. Pathog. 1987, 3, 409–422. [Google Scholar] [CrossRef] [PubMed]
- Chen, S.Y.; Matsuoka, Y.; Compans, R.W. Assembly and polarized release of Punta Toro virus and effects of brefeldin A. J. Virol. 1991, 65, 1427–1439. [Google Scholar] [CrossRef] [PubMed]
- Anderson, G.W., Jr.; Smith, J.F. Immunoelectron microscopy of Rift Valley fever viral morphogenesis in primary rat hepatocytes. Virology 1987, 161, 91–100. [Google Scholar] [CrossRef] [PubMed]
- Rosebrock, J.A.; Schellekens, H.; Peters, C.J. The effects of aging in vitro and interferon on the resistance of rat macrophages to Rift Valley fever virus (RVFV). Anat. Rec. 1983, 205, A165–A166. [Google Scholar]
- do Valle, T.Z.; Billecocq, A.; Guillemot, L.; Alberts, R.; Gommet, C.; Geffers, R.; Calabrese, K.; Schughart, K.; Bouloy, M.; Montagutelli, X.; Panthier, J.J. A new mouse model reveals a critical role for host innate immunity in resistance to Rift Valley fever. J. Immunol. 2010, 185, 6146–6156. [Google Scholar] [CrossRef]
- Latham, P.S.; Sepelak, S.B.; Pifat, D.Y.; Smith, J.F. Role of hepatocytes and Kupffer cells in age-dependent murine hepatitis caused by a phlebovirus, Punta Toro. J. Med. Virol. 1991, 33, 10–18. [Google Scholar] [CrossRef]
- Latham, P.S.; Sepelak, S.B. Effect of macrophage source and activation on susceptibility in an age-dependent model of murine hepatitis caused by a phlebovirus, Punta Toro. Arch. Virol. 1992, 122, 175–185. [Google Scholar] [CrossRef]
- Gowen, B.B.; Hoopes, J.D.; Wong, M.H.; Jung, K.H.; Isakson, K.C.; Alexopoulou, L.; Flavell, R.A.; Sidwell, R.W. TLR3 deletion limits mortality and disease severity due to Phlebovirus infection. J. Immunol. 2006, 177, 6301–6307. [Google Scholar] [CrossRef]
- Wang, T.; Town, T.; Alexopoulou, L.; Anderson, J.F.; Fikrig, E.; Flavell, R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 2004, 10, 1366–1373. [Google Scholar] [CrossRef]
- Najjar, I.; Fagard, R. STAT1 and pathogens, not a friendly relationship. Biochimie 2010, 92, 425–444. [Google Scholar] [CrossRef] [PubMed]
- Mendenhall, M.; Wong, M.H.; Skirpstunas, R.; Morrey, J.D.; Gowen, B.B. Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response. Virology 2009, 395, 143–151. [Google Scholar] [CrossRef] [PubMed]
Model | Advantages | Disadvantages |
---|---|---|
Mouse |
|
|
Rat |
|
|
Hamster |
|
|
Gerbil |
|
|
Rhesus monkey |
|
|
Adult sheep, ewe |
|
|
Lamb |
|
|
© 2011 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
Share and Cite
Ikegami, T.; Makino, S. The Pathogenesis of Rift Valley Fever. Viruses 2011, 3, 493-519. https://doi.org/10.3390/v3050493
Ikegami T, Makino S. The Pathogenesis of Rift Valley Fever. Viruses. 2011; 3(5):493-519. https://doi.org/10.3390/v3050493
Chicago/Turabian StyleIkegami, Tetsuro, and Shinji Makino. 2011. "The Pathogenesis of Rift Valley Fever" Viruses 3, no. 5: 493-519. https://doi.org/10.3390/v3050493